This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. image www.elsevier.com/locate/bios long been demonstrated to increase operative risk, particularly for those patients undergoing cardiac surgery. Several retrospective studies have demonstrated an association between obstruction and chronic obstructive pulmonary disease (COPD) with increased risk of mortality both in the short term and long term. [1] [2] [3] [4] [5] [6] In this issue of the Journal of Cardiothoracic and Vascular Anesthesia, Ponomarev and colleagues 7 present a study looking at 1-year outcomes of patients with pre-existing COPD or newly diagnosed obstruction on pulmonary function testing who are undergoing elective coronary artery bypass grafting. This is a follow-up study of a previously published cohort of prospectively enrolled patients that demonstrated a relationship between abnormal respiratory patterns (either restrictive or obstructive) and increased length of hospital stay, but not mortality. 8 Not surprisingly now the authors find that patients with either COPD or newly diagnosed obstruction have an increased risk of mortality at 1 year. This adds little to the pre-existing understanding of the effect of chronic lung disease to operative risk, with much fewer patients than a previously published prospective study testing the same hypothesis. 4 It does demonstrate reproducibility and robustness of a concept that is well accepted.
Although the concept of obstruction altering a patient's risk of survival post-cardiac surgery is important, this particular study's results should be interpreted with caution. This study had much fewer patients than previously reported studies. In addition, the authors combine obstruction and COPD as a composite group in order to demonstrate a statistically significant effect on mortality in a multivariable model. Obstruction alone was not shown to be an independent risk for mortality. This probably reflects the fact that the number of patients in this study was very small. Finally, the model was not externally validated on a separate population and therefore it is difficult to determine its significance. Given the small size of this study it is difficult to delineate patient factors that would be important in determining if all patients with chronic lung disease were at a higher risk or if there was a select subpopulation of patients where the risks of surgery would perhaps outweigh the benefits.
Perioperative factors that could potentially affect outcomes in this cohort of cardiac surgical patients include: injurious mechanical ventilation and right ventricular (RV) injury, both shown to be independently associated with adverse clinical outcomes. 9, 10 Data relating to perioperative ventilatory strategy and/or postoperative pulmonary compliance in the patient population studied by Ponomarev et al 7 is not provided and therefore it is unknown whether these patients had ventilator induced lung injury (VILI) which would further exacerbate pulmonary morbidity and mortality. Patients with COPD commonly have different pulmonary mechanics (dynamic hyperinflation, higher PEEP requirements) compared with patients without pre-existing lung pathology. In the absence of prospective intraoperative ventilation data in cardiac surgical patients with airflow limitation, a low tidal volume (less than 6ml/kg predicted body weight) and low dynamic stress (avoidance of an increase in driving pressure above 13 cmH 2 O) approach would seem reasonable. 11, 12 None of the retrospective studies 1-7 examining the influence of COPD on postoperative mortality assess perioperative RV function or temporal changes in RV function. In a cohort study of COPD patients who required hospital admission for COPD exacerbation, RV dilatation and pulmonary hypertension on echocardiography was evident in 30% and 19% of patients respectively. 13 Baseline echocardiography is paramount and right heart catheterization may be necessary to assess degree of pulmonary hypertension, optimize pharmacotherapy and risk stratify these patients preoperatively. Currently, there is no evidence-based recommendation for RV-protective ventilatory strategies in COPD patients since most of these patients have chronic hypercapnia and hypoxemia and therefore it is unknown whether they would benefit from acute reduction in arterial carbon dioxide partial pressure (P a CO 2 < 48mmHg) or an increased ratio of arterial oxygen partial pressure to fractional inspired oxygen (P a O 2 /F i O 2 > 150mmHg) shown to be beneficial in patients with acute respiratory distress syndrome and RV dysfunction. 14, 15 COPD patients undergoing cardiac surgery are at a higher operative risk for morbidity and mortality. Although it is not possible to fully reverse airflow limitation and organ dysfunction in COPD, meticulous preoperative screening and work up with particular emphasis on pulmonary rehabilitation and adherence to inhaled agents may confer mortality benefit; however this requires further study. A recently completed randomized controlled trial examined the effect of prophylactic use of high-flow nasal oxygen on patient-centered outcomes, in cardiac surgical patients with pre-existing lung disease. 16 Publication of the results is awaited with interest as if 'positive' it could potentially advance clinical practice in the new era of 'personalized medicine'.
